Related Experiment Videos
Aminoglycoside nephrotoxicity: keys to prevention
1Division of Nephrology/Hypertension, Northwestern University Medical School, Chicago, USA.
The Journal of Critical Illness
|September 5, 1994
Summary
Aminoglycoside nephrotoxicity risk increases with kidney accumulation. Proper dosing based on creatinine clearance and monitoring serum levels can minimize this risk, especially in vulnerable patients.
Area of Science:
- Nephrology
- Pharmacology
- Internal Medicine
Background:
- Kidneys are the main organs for aminoglycoside drug clearance.
- Renal parenchymal accumulation of aminoglycosides elevates nephrotoxicity risk.
- Over-administration, particularly in women and the elderly, is a common cause.
Purpose of the Study:
- To outline strategies for minimizing aminoglycoside-induced kidney damage.
- To emphasize the importance of individualized dosing and therapeutic drug monitoring.
Main Methods:
- Dose selection guided by estimated creatinine clearance.
- Monitoring of peak and trough serum aminoglycoside concentrations.
- Management of fluid balance and electrolyte abnormalities (potassium, magnesium).
Main Results:
- Individualized aminoglycoside dosing based on renal function is crucial.
- Therapeutic drug monitoring aids in preventing toxic accumulation.
- Avoiding concurrent use with nephrotoxic agents is recommended.
Conclusions:
- Optimizing aminoglycoside therapy requires careful consideration of renal function and drug levels.
- Proactive management strategies can significantly reduce the incidence of aminoglycoside nephrotoxicity.